XML 151 R100.htm IDEA: XBRL DOCUMENT v3.23.4
Net Loss Per Share - Weighted-Average Equity Instruments Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Options to purchase common stock              
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]              
Antidilutive securities excluded from computation of earnings per share 3,135,672 351,533 1,426,224 335,395 346,331 264,858 201,977
Unvested restricted stock units              
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]              
Antidilutive securities excluded from computation of earnings per share 0 6,000 252 7,315 6,982 7,975 4,239
Series A Preferred Stock (on an as-converted basis)              
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]              
Antidilutive securities excluded from computation of earnings per share 42,501,681 0 14,851,447 0